Send feedback

BMPR2 p.Cys118Trp

c.354T>G · rs137852743 · VCV8799

Pathogenic Expert panel
Classification
Pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 5 submitters
AlphaMissense
likely pathogenic
0.9994 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 8.5e-05%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
pulmonary arterial hypertension

ClinGen expert panel — Pulmonary Hypertension VCEP

Pathogenic for pulmonary arterial hypertension. Applied ACMG criteria (verbatim):

PM1_Strong PM2_Supporting PM5_Supporting PS3 PS4 PP1 PP3

Curation rationale (ClinGen, verbatim)

The BMPR2 c.354T>C variant is a missense variant predicted to cause a cysteine to tryptophan substitution at amino acid position 118 (p.Cys118Trp). The variant is absent from gnomAD exomes v.2.1.1 controls and gnomAD genomes v3.0 (PM2_supporting). More than 4 unrelated pulmonary arterial hypertension probands were identified with this variant (PMID: 10973254, PMID: 32255665, PMID: 33007923, and PMID: 31727138) (PS4). In one multigenerational family, the variant segregated with PAH in at least 3 family members (PMID: 10973254) (PP1). BMPR2 p.Cys118Trp is located within the conserved extracellular domain and is a Cys residue critical for protein function (PMID: 9886286, PMID: 12221115, PMID: 12045205, PMID: 16429395) (PM1_strong). Several well-controlled in vitro functional assays provided variant-specific evidence of protein loss of function (PMID: 25688877, PMID: 12221115, and PMID: 32255665) (PS3). In silico prediction (REVEL =0.9279) is consistent with a pathogenic effect for this variant (PP3). Additionally, another variant in the same codon, BMPR2 (NM_001204.7):c.353G>A:(p.Cys118Tyr), was classified as likely pathogenic (PM5_supporting). In summary, the variant meets the criteria to be classified as pathogenic for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: PS3, PS4, PM1_strong, PM2_supporting, PM5_supporting, PP3, PP1 (VCEP specification version v 1.1, 1/18/2024).

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.9994likely pathogenic ✓ concordant with ClinVar · top 1% in BMPR2
REVEL0.928moderately pathogenic-leaning
SaProtLLR -15.75damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 2.3GERP -1.1, phastCons 1
Regional constrainto/e 0.78unconstrained · MANE · 153 kb · p 2.6e-06 · regional, not allelic
Overall
CADD28.5PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.5e-05% European (non-Finnish) · 1/1,176,896 alleles
Overall 6.86e-05% 1/1,458,444 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
BMPR2
Protein
p.Cys118Trp
Coding
c.354T>G
MANE Select
NM_001204
dbSNP
rs137852743
Type
single nucleotide variant
Location
chr2:202467625 (GRCh38)
Gene constraint
LOEUF 0.376 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 58.07 · 7 PDB
Residue 118
a disulfide bond; a UniProt-annotated variant site (in pph1; likely pathogenic; loss of function in bmp signaling pathway; does not localize to the cell surface); a β-strand
Full BMPR2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

pulmonary arterial hypertension — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: pulmonary hypertension, primary, 1

For Idiopathic/heritable pulmonary arterial hypertension (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive, Not applicable
Onset
All ages
Prevalence
1-9 / 1 000 000 (United States)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bmpr2-p-cys118trp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown